Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe thrombocytopenic purpura due to brucellosis.

Antigoni Tsirka1, Ioannis Markesinis, Vassiliki Getsi

  • 1Department of Pediatrics, General Hospital G. Chatzikostas, Ioannina, Greece.

Scandinavian Journal of Infectious Diseases
|August 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumococcal meningitis in Greece: A retrospective serotype surveillance study in the post-PCV13 era (2010-2020).

Vaccine·2022
Same author

National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality.

Annals of hematology·2018
Same author

A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.

Annals of hematology·2012
Same author

Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine.

Pediatrics·2011

Brucellosis can rarely cause severe thrombocytopenic purpura, a bleeding disorder, as its only symptom. Early recognition and aggressive treatment are crucial for recovery.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Hematology

Background:

  • Brucellosis is a zoonotic infection with diverse clinical presentations.
  • Hematological abnormalities are known complications of brucellosis, though typically mild.

Observation:

  • An 11-year-old boy presented with severe thrombocytopenic purpura as the sole clinical sign.
  • Initial diagnosis was idiopathic thrombocytopenic purpura, with a positive response to intravenous gamma globulin.

Findings:

  • Blood cultures eventually identified Brucella, despite initial negative results.
  • The patient received a combination therapy of intravenous gentamicin, oral doxycycline, and rifampicin.

Implications:

  • Severe thrombocytopenia can be a rare but significant manifestation of brucellosis.

Related Experiment Videos

  • Prompt diagnosis and aggressive antimicrobial therapy are vital for managing this serious complication.